|
|
||||||||








* Department of Internal Medicine, University of Florence, and
Laboratory of Immunogenetics, Department of Biomedicine, Azienda Ospedaliero-Universitaria di Careggi, Florence, Italy;
Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands; and
Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy
Epidemiological studies suggest the potential importance of an inflammatory component in atherosclerosis and support the hypothesis that immune responses to Ags of pathogens cross-react with homologous host proteins due to molecular mimicry. Protein candidates involved may be the stress-induced proteins known as heat shock proteins (HSP). In this study, we report that atherosclerotic plaques harbor in vivo-activated CD4+ T cells that recognize the human 60-kDa HSP. Such in vivo-activated 60-kDa HSP-specific T cells are not detectable in the peripheral blood. In patients with positive serology and PCR for Chlamydia pneumoniae DNA, but not in patients negative for both, most of plaque-derived T cells specific for human 60-kDa HSP also recognized the C. pneumoniae 60-kDa HSP. We characterized the submolecular specificity of such 60-kDa HSP-specific plaque-derived T cells and identified both the self- and cross-reactive epitopes of that autoantigen. On challenge with human 60-kDa HSP, most of the plaque-derived T cells expressed Th type 1 functions, including cytotoxicity and help for monocyte tissue factor production. We suggest that arterial endothelial cells, undergoing classical atherosclerosis risk factors and conditioned by Th type 1 cytokines, express self 60-kDa HSP, which becomes target for both autoreactive T cells and cross-reactive T cells to microbial 60-kDa HSP via a mechanism of molecular mimicry. This hypothesis is in agreement with the notion that immunization with HSP exacerbates atherosclerosis, whereas immunosuppression and T cell depletion prevent the formation of arteriosclerotic lesions in experimental animals.
This article has been cited by other articles:
![]() |
G.H.M. van Puijvelde, T. van Es, E.J.A. van Wanrooij, K.L.L. Habets, P. de Vos, R. van der Zee, W. van Eden, Th. J.C. van Berkel, and J. Kuiper Induction of Oral Tolerance to HSP60 or an HSP60-Peptide Activates T Cell Regulation and Reduces Atherosclerosis Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2677 - 2683. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Spagnoli, E. Bonanno, G. Sangiorgi, and A. Mauriello Role of Inflammation in Atherosclerosis J. Nucl. Med., November 1, 2007; 48(11): 1800 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. VAN EDEN, G. WICK, S. ALBANI, and I. COHEN Stress, Heat Shock Proteins, and Autoimmunity: How Immune Responses to Heat Shock Proteins Are to Be Used for the Control of Chronic Inflammatory Diseases Ann. N.Y. Acad. Sci., October 1, 2007; 1113(1): 217 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. RIGANỎ, E. PROFUMO, B. BUTTARI, A. TAGLIANI, L. PETRONE, G. D'AMATI, F. IPPOLITI, R. CAPOANO, L. FUMAGALLI, B. SALVATI, et al. Heat Shock Proteins and Autoimmunity in Patients with Carotid Atherosclerosis Ann. N.Y. Acad. Sci., June 1, 2007; 1107(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. BUTTARI, E. PROFUMO, L. PETRONE, D. PIETRAFORTE, A. SIRACUSANO, P. MARGUTTI, F. DELUNARDO, E. ORTONA, M. MINETTI, B. SALVATI, et al. Free Hemoglobin: A Dangerous Signal for the Immune System in Patients with Carotid Atherosclerosis? Ann. N.Y. Acad. Sci., June 1, 2007; 1107(1): 42 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. AYADA, K. YOKOTA, K. KOBAYASHI, Y. SHOENFELD, E. MATSUURA, and K. OGUMA Chronic Infections and Atherosclerosis Ann. N.Y. Acad. Sci., June 1, 2007; 1108(1): 594 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Spagnoli, S. Pucci, E. Bonanno, A. Cassone, F. Sesti, A. Ciervo, and A. Mauriello Persistent Chlamydia pneumoniae Infection of Cardiomyocytes Is Correlated with Fatal Myocardial Infarction Am. J. Pathol., January 1, 2007; 170(1): 33 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Medicherla, A. A. Protter, J. Y. Ma, R. Mangadu, R. Almirez, B. Koppelman, I. Kerr, T. A. Navas, F. Movius, M. Reddy, et al. Preventive and Therapeutic Potential of p38{alpha}-Selective Mitogen-Activated Protein Kinase Inhibitor in Nonobese Diabetic Mice with Type 1 Diabetes J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 99 - 107. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Stoll and M. Bendszus Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization Stroke, July 1, 2006; 37(7): 1923 - 1932. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |